Abhishek Shah, the CEO and founder of Wellthy Therapeutics, is driven by the challenge of improving care delivery and outcomes for serious or chronic diseases like hypertension, type 2 diabetes, and kidney disease. Abhishek decided to start Wellthy after a successful career as an investor; he was inspired by the incredible ideas of other entrepreneurs, and tired of sitting on the sidelines, decided to build something himself.
Eugene and Abhishek talked back in December, and in that time, Wellthy has laid the groundwork for expansion throughout Asia Pacific and Europe. Eugene and Abhishek talk about his efforts to get investors to back Wellthy, the technology and regulatory landscape for DTx in South Asia, and whether Wellthy is facing competition from other industry players like Apollo during the COVID-19 pandemic.
>>Click here to read the transcript
Guest Links and Resources:
Connect with Abhishek Shah: LinkedIn | Twitter
Visit Wellthy Therapeutics: Twitter | LinkedIn | Facebook | Instagram | Website
Host Links and Resources:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Follow Eugene's journey of writing his first book: Hard Pill to Swallow
Connect with YourCoach.health: Website | Twitter
Subscribe to Exits & Outcomes
Brian Dolan: Twitter | LinkedIn
HealthXL: Website | Twitter | Join an Event
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Thank you to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche
